Troponin I Test Kit Market Report 2026

Troponin I Test Kit Market Overview

• Troponin I Test Kit market size has reached to $2.95 billion in 2025 • Expected to grow to $4.52 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Rising Cardiovascular Disease Prevalence Fueling The Growth Of The Market Due To Increasing Demand For Rapid Detection And Early Diagnosis Of Cardiac Injury • Market Trend: High-Sensitivity Assay Development Improves Early Cardiac Diagnosis And Laboratory Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Troponin I Test Kit Market?

A troponin I test kit is a diagnostic medical device used to detect and measure cardiac troponin I (cTnI) levels in blood samples. Troponin I is a protein released into the bloodstream when heart muscle damage occurs, especially during a myocardial infarction. The test kit helps healthcare professionals diagnose acute coronary syndromes and other cardiac conditions quickly and accurately. It commonly uses immunoassay-based technology for rapid and reliable detection. The main product types of troponin I test kit include rapid test kits, enzyme linked immunosorbent assay test kits, chemiluminescence immunoassay kits, fluorescence immunoassay kits, and high sensitivity troponin test kits. Rapid test kits refer to diagnostic assays designed to quickly detect troponin I levels in blood samples for the assessment of cardiac conditions. These kits are designed for sample types including whole blood, serum, and plasma. The various applications involved are acute myocardial infarction diagnosis, myocardial injury detection, heart failure assessment, and risk stratification of patients and they are utilized by end users including hospitals, ambulatory care centers, diagnostic laboratories, emergency departments, clinics, and cardiology clinics.

What Is The Troponin I Test Kit Market Growth Forecast?

The troponin I test kit market size is expected to see strong growth in the next few years. It will grow to $4.52 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of AI enabled diagnostic decision support systems, increasing demand for high sensitivity cardiac biomarkers, growth in decentralized and home based diagnostic testing, rising healthcare investments in emergency cardiac care infrastructure, increasing adoption of automated laboratory diagnostic platforms. Major trends in the forecast period include high sensitivity point of care troponin testing for rapid emergency diagnosis, integration of AI assisted cardiac biomarker interpretation in diagnostic workflows, development of ultra rapid immunoassay based portable troponin test kits, expansion of multi biomarker cardiac panel testing for improved risk stratification, increasing adoption of automated chemiluminescence based troponin testing platforms.

Global Troponin I Test Kit Market Segmentation

1) By Product Type: Rapid Test Kits; Enzyme Linked Immunosorbent Assay Test Kits; Chemiluminescence Immunoassay Kits; Fluorescence Immunoassay Kits; High Sensitivity Troponin Test Kits 2) By Sample Type: Whole Blood; Serum; Plasma 3) By Application: Acute Myocardial Infarction Diagnosis; Myocardial Injury Detection; Heart Failure Assessment; Risk Stratification Of Patients 4) By End User: Hospitals; Ambulatory Care Centers; Diagnostic Laboratories; Emergency Departments; Clinics; Cardiology Clinics Subsegments: 1) By Rapid Test Kits: Lateral Flow Assays; Point Of Care Rapid Tests; Cassette Based Tests; Immunochromatographic Assays; Bedside Cardiac Tests 2) By Enzyme Linked Immunosorbent Assay Test Kits: Sandwich Enzyme Linked Immunosorbent Assay Test Kits; Competitive Enzyme Linked Immunosorbent Assay Test Kits; Quantitative Enzyme Linked Immunosorbent Assay Test Kits; Colorimetric Enzyme Linked Immunosorbent Assay Test Kits; High Sensitivity Enzyme Linked Immunosorbent Assay Test Kits 3) By Chemiluminescence Immunoassay Kits: Automated Chemiluminescence Immunoassay Test Kits; Magnetic Particle Chemiluminescence Immunoassay Kits; High Throughput Chemiluminescence Immunoassay Systems; Quantitative Chemiluminescence Immunoassay Assays; Laboratory Based Chemiluminescence Immunoassay Test Kits 4) By Fluorescence Immunoassay Kits: Quantitative Fluorescence Immunoassay Test Kits; Portable Fluorescence Immunoassay Analyzer Kits; Dry Fluorescence Immunoassay Test Kits; Automated Fluorescence Immunoassay Systems; Point Of Care Fluorescence Immunoassay Test Kits 5) By High Sensitivity Troponin Test Kits: High Sensitivity Cardiac Troponin I Laboratory Test Kits; Ultra Sensitive Immunoassay Troponin I Kits; Emergency Cardiac Screening Troponin I Test Kits; Acute Myocardial Infarction Detection Test Kits; Precision Cardiac Biomarker Detection Assays

What Is The Driver Of The Troponin I Test Kit Market?

The increasing cardiovascular disease prevalence globally is expected to propel the growth of the troponin I test kit market going forward. Cardiovascular disease refers to a group of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, stroke, and myocardial infarction. The cardiovascular disease prevalence is rising due to growing aging populations, which increases the risk of heart-related disorders and chronic health complications. Troponin I test kit helps in cardiovascular disease prevalence globally by enabling rapid and accurate detection of cardiac muscle injury, which helps healthcare professionals diagnose and manage acute cardiac conditions at an early stage. For instance, in Spetember 2025, according to the Heart Failure Society of America, a US-based professional organization, cardiovascular disease caused 919,032 deaths in the United States in 2023, and reflecting an increase of nearly 1.2% compared to the previous year. Therefore, the increasing cardiovascular disease prevalence globally is driving the growth of the troponin I test kit industry.

Key Players In The Global Troponin I Test Kit Market

Major companies operating in the troponin i test kit market are Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; QuidelOrtho; bioMérieux SA; Beckman Coulter; Bio-Rad Laboratories; Randox Laboratories Ltd.; Sekisui Diagnostics LLC; SD BIOSENSOR Inc.; Getein Biotech Inc.; Boditech Med Inc.; YHLO Biotech Co. Ltd.; EDAN Instruments Inc.; Trivitron Healthcare; Sugentech Inc.; Assure Tech (Hangzhou) Co. Ltd.; InTec Products Inc.; Jant Pharmacal Corporation.; Guangzhou Wondfo Biotech Co. Ltd.

Global Troponin I Test Kit Market Trends and Insights

Major companies operating in the troponin I test kit market are focusing on developing advanced solutions, such as high-sensitivity immunoassay manufacturing platforms, to improve analytical precision, accelerate emergency diagnosis workflows, and support earlier detection of myocardial injury. High-sensitivity immunoassay manufacturing platforms refer to advanced diagnostic production systems that enable the detection of extremely low concentrations of cardiac troponin with enhanced assay sensitivity, reproducibility, and rapid turnaround time for clinical laboratories and point-of-care settings. For instance, in October 2024, Siemens Healthineers AG, a Germany-based medical technology company, expanded the clinical application of its Atellica IM High-Sensitivity Troponin I test for advanced cardiovascular risk assessment and emergency diagnostics. The assay provides 10-minute time-to-first-result capability, supports prediction of major adverse cardiac events for up to one year, and delivers highly sensitive cardiac biomarker detection for emergency department workflows.

What Are Latest Mergers And Acquisitions In The Troponin I Test Kit Market?

In January 2025, bioMérieux, a France-based provider of in vitro diagnostics, acquired SpinChip Diagnostics ASA for an undisclosed amount. With this acquisition, bioMérieux aims to strengthen its point-of-care diagnostics portfolio by integrating SpinChip’s rapid immunoassay platform for high-sensitivity cardiac biomarker testing, including troponin I assays used in myocardial infarction diagnosis. SpinChip Diagnostics ASA is a Norway-based company specializing in cardiac biomarker testing such as high-sensitivity Troponin I assays used on its SpinChip platform.

Regional Outlook

North America was the largest region in the troponin I test kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Troponin I Test Kit Market?

The troponin I test kit market consists of sales of cardiac biomarker diagnostic kits, analyzers, and related consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators0 of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Troponin I Test Kit Market Report 2026?

The troponin i test kit market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the troponin i test kit industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.